Literature DB >> 22409933

Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection.

Seung-Jung Kee1, Yong-Soo Kwon, Yong-Wook Park, Young-Nan Cho, Sung-Ji Lee, Tae-Jong Kim, Shin-Seok Lee, Hee-Chang Jang, Myung-Geun Shin, Jong-Hee Shin, Soon-Pal Suh, Dong-Wook Ryang.   

Abstract

Natural killer T (NKT) cells are known to play a protective role in the immune responses of mice against a variety of infectious pathogens. However, little is known about the detailed information of NKT cells in patients with Mycobacterium tuberculosis infection. The aims of this study were to examine NKT cell levels and functions in patients with active M. tuberculosis infection, to investigate relationships between NKT cell levels and clinical parameters, and to determine the mechanism responsible for the poor response to α-galactosylceramide (α-GalCer). NKT cell levels were significantly lower in the peripheral blood of pulmonary tuberculosis and extrapulmonary tuberculosis patients, and the proliferative responses of NKT cells to α-GalCer were also lower in patients, whereas NKT cell levels and responses were comparable in latent tuberculosis infection subjects and healthy controls. Furthermore, this NKT cell deficiency was found to be correlated with serum C-reactive protein levels. In addition, the poor response to α-GalCer in M. tuberculosis-infected patients was found to be due to increased NKT cell apoptosis, reduced CD1d expression, and a defect in NKT cells. Notably, M. tuberculosis infection was associated with an elevated expression of the inhibitory programmed death-1 (PD-1) receptor on NKT cells, and blockade of PD-1 signaling enhanced the response to α-GalCer. This study shows that NKT cell levels and functions are reduced in M. tuberculosis-infected patients and these deficiencies were found to reflect the presence of active tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22409933      PMCID: PMC3370582          DOI: 10.1128/IAI.06018-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity.

Authors:  Young-Nan Cho; Seung-Jung Kee; Sung-Ji Lee; Seong-Rye Seo; Tae-Jong Kim; Shin-Seok Lee; Min-Soo Kim; Won-Woo Lee; Dae-Hyun Yoo; Nacksung Kim; Yong-Wook Park
Journal:  Rheumatology (Oxford)       Date:  2011-01-27       Impact factor: 7.580

Review 2.  NKT cells: what's in a name?

Authors:  Dale I Godfrey; H Robson MacDonald; Mitchell Kronenberg; Mark J Smyth; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

Review 3.  Going both ways: immune regulation via CD1d-dependent NKT cells.

Authors:  Dale I Godfrey; Mitchell Kronenberg
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

4.  Human NKT cells express granulysin and exhibit antimycobacterial activity.

Authors:  Jennifer L Gansert; Viviane Kiessler; Matthias Engele; Frederick Wittke; Martin Röllinghoff; Alan M Krensky; Steven A Porcelli; Robert L Modlin; Steffen Stenger
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

5.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.

Authors:  T Kawano; J Cui; Y Koezuka; I Toura; Y Kaneko; K Motoki; H Ueno; R Nakagawa; H Sato; E Kondo; H Koseki; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

Review 6.  alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.

Authors:  Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

7.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.

Authors:  C Dye; S Scheele; P Dolin; V Pathania; M C Raviglione
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

8.  Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells.

Authors:  M Exley; J Garcia; S P Balk; S Porcelli
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

9.  CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells.

Authors:  F M Spada; Y Koezuka; S A Porcelli
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

10.  Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies.

Authors:  T Crough; D M Purdie; M Okai; A Maksoud; M Nieda; A J Nicol
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640

View more
  34 in total

1.  Clonal enrichments of Vδ2- γδ T cells in Mycobacterium tuberculosis-infected human lungs.

Authors:  Corinna A Kulicke; Deborah A Lewinsohn; David M Lewinsohn
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

2.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

3.  Host directed therapies (HDTs) and immune response signatures: insights into a role for interleukin-32.

Authors:  Markus Maeurer; Martin Rao; Alimuddin Zumla
Journal:  Ann Transl Med       Date:  2015-05

4.  Natural Killer T Cells Are Numerically and Functionally Deficient in Patients with Trauma.

Authors:  Young-Goun Jo; Jung-Chul Kim; Hye-Mi Jin; Young-Nan Cho; Seung-Jung Kee; Yong-Wook Park
Journal:  J Innate Immun       Date:  2020-05-25       Impact factor: 7.349

Review 5.  The Goldilocks model of immune symbiosis with Mycobacteria and Candida colonizers.

Authors:  Richard T Robinson; Anna R Huppler
Journal:  Cytokine       Date:  2017-05-29       Impact factor: 3.861

6.  Role of interferon-γ and cytotoxic T lymphocytes in intraocular tumor rejection.

Authors:  Ann J Ligocki; Joseph R Brown; Jerry Y Niederkorn
Journal:  J Leukoc Biol       Date:  2015-11-17       Impact factor: 4.962

7.  Interleukins 15 and 12 in combination expand the selective loss of natural killer T cells in HIV infection in vitro.

Authors:  Venkata Ramanarao Parasa; Anbalagan Selvaraj; Rajasekaran Sikhamani; Alamelu Raja
Journal:  Clin Exp Med       Date:  2014-04-20       Impact factor: 3.984

8.  Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis.

Authors:  Jennifer E Snyder-Cappione; Douglas F Nixon; Joyce C Chi; Michelle-Linh T Nguyen; Christopher K Kirby; Jeffrey M Milush; Laura L Koth
Journal:  Eur J Immunol       Date:  2013-06-25       Impact factor: 5.532

Review 9.  The role of invariant natural killer T cells in microbial immunity.

Authors:  Yuki Kinjo; Naoki Kitano; Mitchell Kronenberg
Journal:  J Infect Chemother       Date:  2013-07-12       Impact factor: 2.211

10.  Activation of Natural Killer Cells in Patients with Chronic Bone and Joint Infection due to Staphylococci Expressing or Not the Small Colony Variant Phenotype.

Authors:  Sébastien Viel; Paul Rouzaire; Frédéric Laurent; Thierry Walzer; Jacques Bienvenu; Florent Valour; Christian Chidiac; Tristan Ferry; The Lyon Bji Study Group
Journal:  Int J Chronic Dis       Date:  2014-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.